|
1.
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2.
|
Peek RM Jr and Blaser MJ: Helicobacter
pylori and gastrointestinal tract adenocarcinomas. Nature
reviews Cancer. 2:28–37. 2002. View
Article : Google Scholar
|
|
3.
|
Lauren P: The two histological main types
of gastric carcinoma: diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification Acta
Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
4.
|
Correa P: Human gastric carcinogenesis: a
multistep and multifactorial process - First American Cancer
Society Award Lecture on Cancer Epidemiology and Prevention. Cancer
Res. 52:6735–6740. 1992.
|
|
5.
|
Barros R, Freund J-N, David L and Almeida
R: Gastric intestinal metaplasia revisited: function and regulation
of CDX2. Trends Mol Med. 18:555–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Barros R, Camilo V, Pereira B, Freund JN,
David L and Almeida R: Pathophysiology of intestinal metaplasia of
the stomach: emphasis on CDX2 regulation. Biochem Soc Trans.
38:358–363. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Stairs DB, Kong J and Lynch JP: Chapter 10
- Cdx genes, inflammation, and the pathogenesis of intestinal
metaplasia. In Progress in Molecular Biology and Translational
Science. 96. Klaus HK: Academic Press; Philadelphia: pp. 231–270.
2010
|
|
8.
|
Qin R, Wang NN, Chu J and Wang X:
Expression and significance of homeodomain protein Cdx2 in gastric
carcinoma and precancerous lesions. World J Gastroenterol.
18:3296–3302. 2012.PubMed/NCBI
|
|
9.
|
Silberg DG, Sullivan J, Kang E, et al:
Cdx2 ectopic expression induces gastric intestinal metaplasia in
transgenic mice. Gastroenterology. 122:689–696. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Mutoh H, Sakurai S, Satoh K, et al:
Development of gastric carcinoma from intestinal metaplasia in
Cdx2-transgenic mice. Cancer Res. 64:7740–7747. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Seno H, Oshima M, Taniguchi MA, et al:
CDX2 expression in the stomach with intestinal metaplasia and
intestinal-type cancer: Prognostic implications. Int J Oncol.
21:769–774. 2002.PubMed/NCBI
|
|
12.
|
Mizoshita T, Tsukamoto T, Nakanishi H, et
al: Expression of Cdx2 and the phenotype of advanced gastric
cancers: relationship with prognosis. J Cancer Res Clin Oncol.
129:727–734. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Fan Z, Li J, Dong B and Huang X:
Expression of Cdx2 and hepatocyte antigen in gastric carcinoma:
correlation with histologic type and implications for prognosis.
Clin Cancer. 11:6162–6170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Roessler K, Mönig SP, Schneider PM, et al:
Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations
with clinicopathological parameters and prognosis. World J
Gastroenterol. 11:3182–3188. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Gil A, Andrés-Pons A, Fernández E, et al:
Nuclear localization of PTEN by a Ran-dependent mechanism enhances
apoptosis: involvement of an N-terminal nuclear localization domain
and multiple nuclear exclusion motifs. Mol Biol Cell. 17:4002–4013.
2006. View Article : Google Scholar
|
|
16.
|
Sansal I and Sellers WR: The biology and
clinical relevance of the PTEN tumor suppressor pathway. J Clin
Oncol. 22:2954–2963. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Tamura M, Gu J, Matsumoto K, Aota S,
Parsons R and Yamada KM: Inhibition of cell migration, spreading,
and focal adhesions by tumor suppressor PTEN. Science.
280:1614–1617. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Shen WH, Balajee AS, Wang J, et al:
Essential role for nuclear PTEN in maintaining chromosomal
integrity. Cell. 128:157–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Bai Z, Ye Y, Chen D, et al: Homeoprotein
Cdx2 and nuclear PTEN expression profiles are related to gastric
cancer prognosis. APMIS. 115:1383–1390. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kim S, Domon-Dell C, Wang Q, et al: PTEN
and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox
gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.
Gastroenterology. 123:1163–1178. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Hinoi T, Gesina G, Akyol A, et al:
CDX2-regulated expression of iron transport protein hephaestin in
intestinal and colonic epithelium. Gastroenterology. 128:946–961.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Yuasa Y: Control of gut differentiation
and intestinal-type gastric carcinogenesis. Nature reviews. Cancer.
3:592–600. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Xu Y, Zhang J, Liu QS and Dong WG:
Knockdown of liver-intestine cadherin decreases BGC823 cell
invasiveness and metastasis in vivo. World J Gastroenterol.
18:3129–3137. 2012.PubMed/NCBI
|
|
24.
|
Wu T, Li JY and Lu SX: Isolation and
characterization of side population cells in human gastric cancer
cell line BGC-823. Zhonghua Zhong Liu Za Zhi. 34:264–268. 2012.In
Chinese.
|
|
25.
|
Dang LH, Chen F, Knock SA, et al: CDX2
does not suppress tumorigenicity in the human gastric cancer cell
line MKN45. Oncogene. 25:2048–2059. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Wrighton KH: Tumour suppressors: role of
nuclear PTEN revealed. Nature reviews Cancer. 11:154. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Pereira B, Oliveira C, David L and Almeida
R: CDX2 promoter methylation is not associated with mRNA
expression. Int J Cancer. 125:1739–1742. 2009. View Article : Google Scholar : PubMed/NCBI
|
